TipRanks
Go Ultimate55% OFF

Vuong Trieu Insider Profile

4 Followers

Vuong Trieu, Chairman & CEO, Director, Ten Percent Owner at Oncotelic Therapeutics, holds 119.13M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Oct 30, 2026 for an estimated value of $13.57K.

Vuong Trieu's Trading History

OTLC
Oncotelic Therapeutics
Oct 30, 2026Chairman & CEO, Director, Ten Percent OwnerInformative Buy13.57K$1.91M
SRNE
Sorrento Therapeutics
Sep 19, 2013CSO, DirectorUninformative Buy――

You May Also Like

Vuong Trieu insider profile FAQ

What is the percentage of profitable transactions made by Vuong Trieu?
The percentage of profitable transactions made by Vuong Trieu is 54%.
What is the average return per transaction made by Vuong Trieu?
The average return per transaction made by Vuong Trieu is 18.20%.
What stocks does Vuong Trieu hold?
Vuong Trieu holds: OTLC, SRNE stocks.
What was Vuong Trieu’s latest transaction?
Vuong Trieu’s latest transaction was an Informative Buy of $13.57K.
What was Vuong Trieu's most profitable transaction?
Vuong Trieu’s most profitable transaction was an Informative Buy of OTLC stock on November 26, 2024. The return on the trade was 212.90%.
What is Vuong Trieu's role in Oncotelic Therapeutics?
Vuong Trieu's role in Oncotelic Therapeutics is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.